BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Gross Margin 2019–2025
Current and historical gross margin for BridgeBio Pharma, Inc. (BBIO) over the last 10 years. The current gross profit margin for BridgeBio Pharma, Inc. as of December 31, 2025 is 95.82%.
From: 12/31/2019To: 12/31/2025
Revenue
Gross Profit
Gross Margin
BridgeBio Pharma, Inc. Gross Margin — FAQ
BridgeBio Pharma, Inc. (BBIO) gross margin over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is BridgeBio Pharma, Inc.'s gross margin?
BridgeBio Pharma, Inc. (BBIO) reported gross margin of 95.8% for fiscal 2025.
Where can I see BBIO's gross margin history?
The chart and table above show BridgeBio Pharma, Inc.'s gross margin by year and by quarter, including the growth rate.